Canopy Growth Corporation

NASDAQ:CGC

Drug Manufacturers - Specialty & Generic

Healthcare
$0.50 +1.07%

+$0.01 today

Market cap
$212.31M
Beta
0.78
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $0.84High $2.38

Volume 3.44M

Average 9.97M

CGC Total Debt

Short-term and long-term borrowings combined.

Canopy Growth CorporationNASDAQ: CGC

Total Debt · Q4 FY2025 · quarter ended Mar 2026

Total debt falls 20.0% from a year ago

Total debt stood at CA$278.71M at the end of Q4 FY2025, down 20.0% from a year earlier and down 20.4% from the prior quarter. Over 3 fiscal years it compounded at -38.7% a year.

Context

  • Total debt amounted to 24.9% of total assets at the end of Q4 FY2025, down 13.1 pp from a year earlier.
  • Total debt increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether total debt keeps falling in the next quarterly balance sheet after a -20.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$278.71M-20.4% QoQ
Last fiscal yearMar 2026
CA$325.44M-6.6% YoY
Year agoMar 2025
CA$348.4M-20.0% since
Total Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-20.0%——
1 year-6.6%——
3-year CAGR-38.7%——
5-year CAGR——
10-year CAGR——

Total Debt history

CAD · from the balance sheet

Latest · FY2025
325.44M CAD
Year-over-year change
-6.6%
4-year CAGR
-33.3%

Total Debt vs competitors

How CGC compares with its peers on the latest reported figures

  • Peers report in different currencies, so total debt is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -20.0% is the 5th highest of 9, against a peer median of -17.3%.
  • Total debt amounts to 24.9% of total assets for CGC, versus a peer median of 14.9%.
CGC Competitors
Total Debt for CGC and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
IRWDIronwood Pharmaceuticals, Inc.Mar 2026$597.36M USD-0.3%+12.9%137.5%
CGCCanopy Growth CorporationMar 2026CA$278.71M CAD-20.0%-38.7%24.9%
DHDefinitive Healthcare Corp.Mar 2026$169.84M USD-6.0%-14.5%33.0%
LFCRLifecore Biomedical, Inc.Dec 2025$142.61M USD——61.4%
LYELLyell Immunopharma, Inc.Mar 2026$48.85M USD-14.4%-9.0%13.9%
CABACabaletta Bio, Inc.Mar 2026$26.45M USD-8.1%+74.1%17.9%
ACBAurora Cannabis Inc.Mar 2026CA$23.92M CAD-77.0%-52.7%4.0%
TKNOAlpha Teknova, Inc.Mar 2026$14.66M USD-50.1%-29.0%14.9%
BIOABioAge Labs, Inc.Mar 2026$4.03M USD-60.9%+31.1%1.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$1.99M USD-20.1%+45.7%1.0%
Peer median (excluding CGC) —-17.3%+1.9%14.9%

Competitors are the stored peer set for CGC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Cash & Equivalents776.01M667.69M170.3M113.81M508.58M
Short-term Investments595.65M105.53M33.16M17.66M5.06M
Net Receivables86.58M68.46M51.85M52.78M36.29M
Inventory204.54M83.23M77.29M96.37M154.12M
Other Current Assets31.28M138.17M29.59M8.44M39.39M
Total Current Assets1.73B1.08B371.18M294.57M738.38M
Property, Plant & Equipment (Net)942.78M471.27M320.1M293.52M441.37M
Goodwill1.87B85.56M43.24M46.04M77.66M
Intangible Assets252.7M160.75M104.05M87.2M128.87M
Long-term Investments341.73M568.29M136.22M35.29M150.63M
Tax Assets00000
Other Non-current Assets473.94M76.57M325.53M161.07M23.24M
Total Non-current Assets3.88B1.36B929.15M623.13M821.77M
Total Assets5.61B2.44B1.3B917.7M1.56B
Account Payables64.27M31.84M28.67M26.1M34.82M
Short-term Debt9.3M556.89M103.94M4.26M22.64M
Tax Payables7.14M5.73M10.52M13.07M0
Deferred Revenue005.85M00
Other Current Liabilities76.71M175M53.77M31.73M134.77M
Total Current Liabilities213.19M803.84M234.72M94.4M220.96M
Long-term Debt1.49B749.99M493.29M299.81M302.79M
Deferred Tax Liabilities15.99M357K0011.43M
Deferred Revenue (Non-current)00000
Other Non-current Liabilities162.84M47.12M16.22M8.49M6.35M
Total Non-current Liabilities1.77B875.83M565.11M336.08M366.35M
Total Liabilities1.98B1.68B799.82M430.49M587.31M
Common Stock7.48B7.94B8.24B8.8B9.23B
Retained Earnings(6.38B)(9.67B)(10.33B)(10.93B)(11.14B)
Accumulated OCI(42.28M)(13.86M)(16.05M)535K10.53M
Other Stockholders Equity00000
Minority Interest36.84M1.59M139K00
Total Equity3.62B760.02M500.51M487.21M972.84M
Total Debt1.64B1.41B668M348.4M325.44M
Net Debt864.15M745.98M497.7M234.59M(183.14M)

Canopy Growth Corporation

NASDAQ:CGC

Intrinsic Alpha fair value

Locked

Current Price

$0.50

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.